Home NDC 67877-452-30 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Product NDC 67877-452
Requested package NDC 67877-452-30
11-digit product format 678770452
Labeler code 67877
Product ID 67877-452_b9b67a37-65d5-47fb-a417-0e8901f27f22
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Ascend Laboratories, LLC
Application ANDA207037
Marketing category ANDA
Marketing start 2025-05-01
Substance OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
Active strength 40; 12.5 mg/1; mg/1
Pharmacologic classes Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A207037-001 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 A207037-002 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL 12.5MG;40MG TABLET / ORAL AB 2024-07-11 A207037-003 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL 25MG;40MG TABLET / ORAL AB 2024-07-11
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 48 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A207037-001 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2024-07-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A207037-002 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;40MG TABLET / ORAL AB 2024-07-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A207037-003 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL AB 2024-07-11 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A207037-001 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2024-07-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 A207037-002 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;40MG TABLET / ORAL AB 2024-07-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 A207037-003 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL AB 2024-07-11 c2088c7a36db…2026-09-14 22:38:34 2026-08 A207037-001 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2024-07-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207037-002 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;40MG TABLET / ORAL AB 2024-07-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207037-003 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL AB 2024-07-11 84e616aacf4f…2026-08-18 06:07:40 2026-07 A207037-001 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2024-07-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207037-002 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;40MG TABLET / ORAL AB 2024-07-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207037-003 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL AB 2024-07-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A207037-001 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2024-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207037-002 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;40MG TABLET / ORAL AB 2024-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207037-003 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL AB 2024-07-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207037-001 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;20MG TABLET / ORAL AB 2024-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207037-002 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 12.5MG;40MG TABLET / ORAL AB 2024-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207037-003 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 25MG;40MG TABLET / ORAL AB 2024-07-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A207037-001 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207037-002 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;40MG TABLET / ORAL AB 2024-07-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207037-003 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 25MG;40MG TABLET / ORAL AB 2024-07-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207037-001 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207037-002 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;40MG TABLET / ORAL AB 2024-07-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207037-003 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 25MG;40MG TABLET / ORAL AB 2024-07-11 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207037-001 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207037-002 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;40MG TABLET / ORAL AB 2024-07-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207037-003 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 25MG;40MG TABLET / ORAL AB 2024-07-11 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207037-001 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207037-002 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;40MG TABLET / ORAL AB 2024-07-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207037-003 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 25MG;40MG TABLET / ORAL AB 2024-07-11 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207037-001 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207037-002 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;40MG TABLET / ORAL AB 2024-07-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207037-003 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 25MG;40MG TABLET / ORAL AB 2024-07-11 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207037-001 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207037-002 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;40MG TABLET / ORAL AB 2024-07-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207037-003 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 25MG;40MG TABLET / ORAL AB 2024-07-11 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207037-001 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207037-002 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;40MG TABLET / ORAL AB 2024-07-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207037-003 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 25MG;40MG TABLET / ORAL AB 2024-07-11 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A207037-001 HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL 12.5MG;20MG TABLET / ORAL AB 2024-07-11 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 48 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength OLMESARTAN MEDOXOMIL 40 mg/1 HYDROCHLOROTHIAZIDE 12.5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 6M97XTV3HD Internal UNII lookup 0J48LPH2TH Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 403853 Internal RxNorm lookup 403854 Internal RxNorm lookup 403855 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67877-452-30 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 30 in 1 BOTTLE TABLET, FILM COATED 30 5 67877-452-90 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE 90 in 1 BOTTLE TABLET, FILM COATED 90 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67877-452 OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [ASCEND LABORATORIES, LLC] 5 Current NDC, 2 package rows 20250501_798fee33-51ad-45d0-82f3-09289304139f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 67877-452-30 67877045230 30 TABLET, FILM COATED in 1 BOTTLE (67877-452-30) 2025-05-01 No No Current